ESC 365 - Reporting quality of randomised controlled trials investigating efficacy of pharmacological therapies for heart failure with preserved ejection fraction

HFA Premium Access

Reporting quality of randomised controlled trials investigating efficacy of pharmacological therapies for heart failure with preserved ejection fraction

Session: Poster Session 3 - HFpEF - Heart failure with preserved ejection fraction

Topic: HFpEF - Heart failure with preserved ejection fraction

Speaker: Doctor S. Zheng (London, GB)

Event: HEART FAILURE 2016

Congress Presentation

Add to my library

About the speaker

Doctor Sean Zheng

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

2 followers

7 more presentations in this session

The role of diastolic heart failure in the development of atrial fibrillation paroxysms in patients with hypertension

Speaker: Doctor D. Pilant (Minsk, BY)

Features of very elderly heart failure patients between heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.

Speaker: Mr K. Satogami (Shingu, JP)

Heart failure with preserved ejection fraction: is the role of arterial stiffness established?

Speaker: Doctor E. Gorga (Brescia, IT)

Timing of left ventricular deformation and dyssynchrony in HFpEF and treated arterial hypertension

Speaker: Associate Professor M. Cikes (Zagreb, HR)

Diagnosis, clinical course and one-year outcome in patients hospitalized for heart failure with preserved ejection fraction - results from the polish cohort of the ESC-HF long-term registry

Speaker: Professor A. Kaplon Cieslicka (Warsaw, PL)

Access the full session

Poster Session 3 - HFpEF - Heart failure with preserved ejection fraction

Speakers: Doctor S. Zheng, Doctor D. Pilant, Mr K. Satogami, Doctor E. Gorga, Associate Professor M. Cikes...

About the event

HEART FAILURE 2016

21 May - 24 May 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources